Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 12-Sep-24 5:59 PM View:  | Carulli Michael Chief Financial Officer | Pmv Pharmaceuticals, Inc. (PMVP) | 11-Sep-24 | Sale | 2,891 | $1.50 | $4,346.91 | (3%) 91.29K to 88.39K | |
| 12-Sep-24 6:00 PM View: | Jalota Deepika Chief Development Officer | Pmv Pharmaceuticals, Inc. (PMVP) | 11-Sep-24 | Sale | 7,218 | $1.50 | $10,853.00 | (6%) 125.5K to 118.28K | |
| 22-Jan-24 4:02 PM View: | MacK David Henry President and CEO Director | Pmv Pharmaceuticals, Inc. (PMVP) | 18-Jan-24 | Grant | 163,890 | -- | -- | 25% 648.77K to 812.66K | |
| 22-Jan-24 4:04 PM View: | Carulli Michael Chief Financial Officer | Pmv Pharmaceuticals, Inc. (PMVP) | 18-Jan-24 | Grant | 82,220 | -- | -- | 907% 9.07K to 91.29K | |
| 22-Jan-24 4:06 PM View: | Jalota Deepika Chief Development Officer | Pmv Pharmaceuticals, Inc. (PMVP) | 18-Jan-24 | Grant | 95,555 | -- | -- | 319% 29.95K to 125.5K | |
| 24-Nov-23 4:38 PM View: | Orbimed Advisors LLC 10% Owner | Pmv Pharmaceuticals, Inc. (PMVP) | 22-Nov-23 | Sale | 87,786 | $2.23 | $195,763.00 | (1%) 6.56M to 6.48M | |
| 13-Nov-23 4:21 PM View: | MacK David Henry President and CEO Director | Pmv Pharmaceuticals, Inc. (PMVP) | 10-Nov-23 | Gift | 85,307 | -- | -- | (12%) 734.08K to 648.77K | |
| 13-Nov-23 4:21 PM View: | MacK David Henry President and CEO Director | Pmv Pharmaceuticals, Inc. (PMVP) | 10-Nov-23 | Gift | 85,307 | -- | -- | 13% 648.77K to 734.08K | |
| 13-Nov-23 4:21 PM View: | MacK David Henry President and CEO Director | Pmv Pharmaceuticals, Inc. (PMVP) | 18-Oct-23 | Option Exercise | 198,407 | $0.53 | $105,156.00 | 44% 450.36K to 648.77K | |
| 18-Sep-23 4:22 PM View: | Alland Leila Chief Medical Officer | Pmv Pharmaceuticals, Inc. (PMVP) | 15-Sep-23 | Sale | 6,291 | $6.62 | $41,646.40 | (12%) 52.2K to 45.91K | |
| 18-Sep-23 4:26 PM View: | Jalota Deepika Chief Development Officer | Pmv Pharmaceuticals, Inc. (PMVP) | 15-Sep-23 | Sale | 4,104 | $6.62 | $27,168.50 | (12%) 34.05K to 29.95K | |
| 08-Aug-23 4:43 PM View: | MacK David Henry President and CEO Director | Pmv Pharmaceuticals, Inc. (PMVP) | 07-Aug-23 | Option Exercise | 85,500 | $0.53 | $45,315.00 | 23% 364.86K to 450.36K | |
| 30-Jan-23 4:22 PM View: | Kung Winston COO, CFO | Pmv Pharmaceuticals, Inc. (PMVP) | 25-Nov-22 | Gift | 2,560 | -- | -- | (19%) 13.16K to 10.6K | |
| 13-Sep-22 4:23 PM View: | Alland Leila Chief Medical Officer | Pmv Pharmaceuticals, Inc. (PMVP) | 09-Sep-22 | Grant | 52,200 | -- | -- | 100% 0 to 52.2K | |
| 13-Sep-22 4:26 PM View: | Jalota Deepika SVP, Regulatory Affairs and QA | Pmv Pharmaceuticals, Inc. (PMVP) | 09-Sep-22 | Grant | 34,050 | -- | -- | 100% 0 to 34.05K | |
| 31-May-22 4:36 PM View: | Orbimed Advisors LLC 10% Owner | Pmv Pharmaceuticals, Inc. (PMVP) | 26-May-22 | Market Sale | 26,253 | $15.93 | $418,210.00 | (< 1%) 6.59M to 6.56M | (13%) |
| 29-Apr-22 9:15 PM View: | MacK David Henry President and CEO Director | Pmv Pharmaceuticals, Inc. (PMVP) | 27-Apr-22 | Option Exercise | 33,000 | $0.53 | $17,490.00 | 10% 331.86K to 364.86K | |
| 21-Apr-22 4:25 PM View: | Kung Winston COO, CFO | Pmv Pharmaceuticals, Inc. (PMVP) | 20-Apr-22 | Option Exercise | 4,000 | $3.22 | $12,880.00 | 61% 6.6K to 10.6K | |
| 31-Mar-22 5:30 PM View: | Orbimed Advisors LLC 10% Owner | Pmv Pharmaceuticals, Inc. (PMVP) | 31-Mar-22 | Sale | 34,500 | $21.17 | $730,365.00 | (< 1%) 6.62M to 6.59M | |
| 31-Mar-22 5:30 PM View: | Orbimed Advisors LLC 10% Owner | Pmv Pharmaceuticals, Inc. (PMVP) | 30-Mar-22 | Sale | 75,000 | $22.39 | $1,679,250.00 | (1%) 6.7M to 6.62M | |
| 31-Mar-22 5:30 PM View: | Orbimed Advisors LLC 10% Owner | Pmv Pharmaceuticals, Inc. (PMVP) | 29-Mar-22 | Private Sale | 365,000 | $21.52 | $7,854,800.00 | (5%) 7.06M to 6.7M | |
| 09-Mar-22 4:33 PM View: | MacK David Henry President and CEO Director | Pmv Pharmaceuticals, Inc. (PMVP) | 08-Mar-22 | Option Exercise | 20,000 | $1.37 | $27,400.00 | 6% 311.86K to 331.86K | |
| 08-Feb-22 4:25 PM View: | Kung Winston COO, CFO | Pmv Pharmaceuticals, Inc. (PMVP) | 30-Dec-21 | Gift | 2,725 | -- | -- | (29%) 9.32K to 6.6K | |
| 16-Dec-21 9:57 PM View: | MacK David Henry President and CEO Director | Pmv Pharmaceuticals, Inc. (PMVP) | 15-Dec-21 | Option Exercise | 9,000 | $0.53 | $4,770.00 | 3% 302.86K to 311.86K | |
| 16-Dec-21 9:57 PM View: | MacK David Henry President and CEO Director | Pmv Pharmaceuticals, Inc. (PMVP) | 09-Dec-21 | Gift | 40,000 | -- | -- | (12%) 342.86K to 302.86K | |
| 16-Dec-21 9:57 PM View: | MacK David Henry President and CEO Director | Pmv Pharmaceuticals, Inc. (PMVP) | 09-Dec-21 | Gift | 40,000 | -- | -- | 13% 302.86K to 342.86K | |
| 08-Oct-21 5:57 PM View: | Schroeder Thilo Director | Pmv Pharmaceuticals, Inc. (PMVP) | 06-Oct-21 | Market Sale (Planned) | 800 | $30.15 | $24,120.00 | (< 1%) 1.1M to 1.1M | 4% |
| 04-Oct-21 8:13 PM View: | Schroeder Thilo Director | Pmv Pharmaceuticals, Inc. (PMVP) | 04-Oct-21 | Market Sale (Planned) | 100 | $30.08 | $3,008.00 | (< 1%) 1.1M to 1.1M | (< 1%) |
| 04-Oct-21 8:13 PM View: | Schroeder Thilo Director | Pmv Pharmaceuticals, Inc. (PMVP) | 01-Oct-21 | Market Sale (Planned) | 11,541 | $30.10 | $347,384.00 | (1%) 1.11M to 1.1M | (< 1%) |
| 04-Oct-21 8:13 PM View: | Schroeder Thilo Director | Pmv Pharmaceuticals, Inc. (PMVP) | 30-Sep-21 | Market Sale (Planned) | 2,978 | $30.03 | $89,429.30 | (< 1%) 1.12M to 1.11M | (< 1%) |
| 29-Sep-21 5:47 PM View: | Schroeder Thilo Director | Pmv Pharmaceuticals, Inc. (PMVP) | 29-Sep-21 | Market Sale (Planned) | 5,708 | $30.04 | $171,468.00 | (< 1%) 1.12M to 1.12M | < 1% |
| 29-Sep-21 5:47 PM View: | Schroeder Thilo Director | Pmv Pharmaceuticals, Inc. (PMVP) | 27-Sep-21 | Market Sale (Planned) | 1,753 | $30.11 | $52,782.80 | (< 1%) 1.12M to 1.12M | 1% |
| 24-Sep-21 10:00 PM View: | Schroeder Thilo Director | Pmv Pharmaceuticals, Inc. (PMVP) | 22-Sep-21 | Market Sale (Planned) | 100 | $30.00 | $3,000.00 | (< 1%) 1.12M to 1.12M | 2% |
| 23-Sep-21 10:00 PM View: | Levine Arnold J Director | Pmv Pharmaceuticals, Inc. (PMVP) | 22-Sep-21 | Market Sale (Planned) | 3,500 | $30.00 | $105,000.00 | (< 1%) 413.34K to 409.84K | 2% |
| 21-Sep-21 10:00 PM View: | Schroeder Thilo Director | Pmv Pharmaceuticals, Inc. (PMVP) | 17-Sep-21 | Market Sale (Planned) | 711 | $30.03 | $21,351.30 | (< 1%) 1.12M to 1.12M | 3% |
| 13-Sep-21 8:21 PM View: | Schroeder Thilo Director | Pmv Pharmaceuticals, Inc. (PMVP) | 13-Sep-21 | Market Sale (Planned) | 13,272 | $30.20 | $400,814.00 | (1%) 1.14M to 1.12M | (2%) |
| 13-Sep-21 8:21 PM View: | Schroeder Thilo Director | Pmv Pharmaceuticals, Inc. (PMVP) | 10-Sep-21 | Market Sale (Planned) | 43,227 | $30.51 | $1,318,880.00 | (4%) 1.18M to 1.14M | (< 1%) |
| 13-Sep-21 8:21 PM View: | Schroeder Thilo Director | Pmv Pharmaceuticals, Inc. (PMVP) | 09-Sep-21 | Market Sale (Planned) | 14,329 | $30.31 | $434,312.00 | (1%) 1.2M to 1.18M | (1%) |
| 10-Sep-21 4:14 PM View: | Alland Leila Chief Medical Officer | Pmv Pharmaceuticals, Inc. (PMVP) | 09-Sep-21 | Market Option Sale (Planned) | 100 | $30.25 | $3,025.00 | (100%) 100 to 0 | |
| 10-Sep-21 4:14 PM View: | Alland Leila Chief Medical Officer | Pmv Pharmaceuticals, Inc. (PMVP) | 09-Sep-21 | Option Exercise | 100 | $3.90 | $390.00 | 100% 0 to 100 | |
| 08-Sep-21 4:22 PM View: | Alland Leila Chief Medical Officer | Pmv Pharmaceuticals, Inc. (PMVP) | 07-Sep-21 | Option Exercise | 3,900 | $3.90 | $15,210.00 | 100% 0 to 3.9K | |
| 08-Sep-21 4:22 PM View: | Alland Leila Chief Medical Officer | Pmv Pharmaceuticals, Inc. (PMVP) | 07-Sep-21 | Market Option Sale (Planned) | 3,900 | $30.25 | $117,975.00 | (100%) 3.9K to 0 | |
| 02-Sep-21 8:47 PM View: | Schroeder Thilo Director | Pmv Pharmaceuticals, Inc. (PMVP) | 02-Sep-21 | Market Sale (Planned) | 5,400 | $30.15 | $162,810.00 | (< 1%) 1.2M to 1.2M | (< 1%) |
| 02-Sep-21 8:47 PM View: | Schroeder Thilo Director | Pmv Pharmaceuticals, Inc. (PMVP) | 01-Sep-21 | Market Sale (Planned) | 21,986 | $30.38 | $667,935.00 | (2%) 1.22M to 1.2M | < 1% |
| 02-Sep-21 8:47 PM View: | Schroeder Thilo Director | Pmv Pharmaceuticals, Inc. (PMVP) | 31-Aug-21 | Market Sale (Planned) | 19,520 | $30.12 | $587,942.00 | (2%) 1.24M to 1.22M | (< 1%) |
| 30-Aug-21 7:52 PM View: | Schroeder Thilo Director | Pmv Pharmaceuticals, Inc. (PMVP) | 30-Aug-21 | Market Sale (Planned) | 13,233 | $30.05 | $397,652.00 | (1%) 1.26M to 1.24M | (< 1%) |
| 30-Aug-21 7:52 PM View: | Schroeder Thilo Director | Pmv Pharmaceuticals, Inc. (PMVP) | 27-Aug-21 | Market Sale (Planned) | 24,442 | $30.52 | $746,066.00 | (2%) 1.28M to 1.26M | 1% |
| 30-Aug-21 7:52 PM View: | Schroeder Thilo Director | Pmv Pharmaceuticals, Inc. (PMVP) | 26-Aug-21 | Market Sale (Planned) | 21,154 | $30.60 | $647,377.00 | (2%) 1.3M to 1.28M | 1% |
| 25-Aug-21 8:25 PM View: | Schroeder Thilo Director | Pmv Pharmaceuticals, Inc. (PMVP) | 25-Aug-21 | Market Sale (Planned) | 13,526 | $31.01 | $419,441.00 | (< 1%) 1.6M to 1.59M | (1%) |
| 25-Aug-21 8:25 PM View: | Schroeder Thilo Director | Pmv Pharmaceuticals, Inc. (PMVP) | 24-Aug-21 | Market Sale (Planned) | 14,490 | $31.08 | $450,349.00 | (< 1%) 1.61M to 1.6M | (1%) |
